SPY312.23+1.71 0.55%
DIA258.42+1.11 0.43%
IXIC10,207.63+53.00 0.52%

Cantor Fitzgerald Maintains Overweight on Globus Medical, Raises Price Target to $64

Cantor Fitzgerald maintains Globus Medical (NYSE:GMED) with a Overweight and raises the price target from $55 to $64.

Benzinga · -

Cantor Fitzgerald maintains Globus Medical (NYSE:GMED) with a Overweight and raises the price target from $55 to $64.